Overview
Thomas Sauermilch concentrates in cross-border mergers and acquisitions, joint ventures and other complex cross-border corporate/commercial transactions for major multinational corporations, private equity funds and their portfolio companies and medium-sized businesses. He also advises clients in corporate governance and compliance matters. He has led transactions in a wide range of sectors, including aerospace and avionics, automotive industries, chemicals, energy, engineering, manufacturing, media, medical devices and scientific instruments, metals and natural resources, packaging, pharmaceuticals, semiconductor equipment, software, technology and trading in North and South America, Europe and Asia. He has been recognized over many years by leading legal directories and nominated as Lawyer of the Year by The Deal (2018) and Dealmaker of the Year by M&A Advisor (2017).
Thomas is a former chair of the Firm’s Global M&A Practice.
Results
- Represented a leading specialty chemicals company in its $3.8 billion acquisition of a worldwide specialty and additives business, its $1.6 billion acquisition of pharmaceutical manufacturing operations and strategic alliance with a major US based pharmaceutical company, its $2 billion acquisition of the worldwide personal care business of and strategic alliance with a leading US chemicals company and numerous other acquisitions, divestitures and joint ventures
- Represented a US mining company in the $700 million sale to a publicly listed Canadian mining company and related equity offering and debt financing and subsequent $650 million acquisition of a Canadian mining company
- Represented a European life sciences company in various acquisitions, disposals and joint ventures including the $725 million acquisition of a pharmaceutical container business and a worldwide joint venture for life sciences products and the sale of its worldwide pharmaceutical glass tubing operations to and joint venture with a major US based glass and materials science company
- Represented a major Japanese trading company in investments in the US health care industry
- Represented one of the largest beverage companies in South America in a complex transaction with a global beer company involving the termination of a license to a prominent beer brand in consideration for payments of $400 million plus the transfer of rights to seven prominent beer brands
Recognitions
- Nominated as Lawyer of the Year by The Deal, 2018
- Nominated for Dealmaker of the Year by M&A Advisorwith respect to Evonik’s $3.8 billion acquisition of the global performance materials division of Air Products and Chemicals, 2017
- Acritas Star Lawyer, 2016 to 2020 (noting his high level of expertise, strong advocacy skills and pragmatic approach)
- Chambers USA, 2006 to 2014 (noting his experience, practicality and perfect understanding of different legal cultures)
- Client Choice Awards 2016, sole winner in the M&A category (New York)
- Law and Politics, Super Lawyer for M&A international business transactions
- The Legal 500 United States, 2009, 2010, 2011, 2013, 2014, 2017, 2018 (noting his exceptional work and creativity in structuring many transactions)
- Super Lawyers, 2006 to 2008, 2011 to present
Community
- American Bar Association
- American Council on Germany
- International Bar Association
